{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:21:40Z","timestamp":1785522100041,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770804"],"award-info":[{"award-number":["81770804"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770804"],"award-info":[{"award-number":["81770804"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Guangdong Province","award":["2014A020212177"],"award-info":[{"award-number":["2014A020212177"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s12020-020-02259-8","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T09:03:35Z","timestamp":1584954215000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of subclinical hyperthyroidism on osteoporosis: A meta-analysis of cohort studies"],"prefix":"10.1007","volume":"69","author":[{"given":"Ningning","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"issue":"6","key":"2259_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"Osteoporosis prevention, diagnosis, and therapy.","year":"2001","unstructured":"Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6), 785\u2013795 (2001). https:\/\/doi.org\/10.1001\/jama.285.6.785","journal-title":"JAMA"},{"issue":"24 Suppl.","key":"2259_CR2","doi-asserted-by":"publisher","first-page":"12S","DOI":"10.1097\/00007632-199712151-00003","volume":"22","author":"DL Glaser","year":"1997","unstructured":"D.L. Glaser, F.S. Kaplan, Osteoporosis. Definition and clinical presentation. Spine 22(24 Suppl.), 12S\u201316S (1997). https:\/\/doi.org\/10.1097\/00007632-199712151-00003","journal-title":"Spine"},{"issue":"2 Suppl.","key":"2259_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"N.E. Lane, Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194(2 Suppl.), S3\u2013S11 (2006). https:\/\/doi.org\/10.1016\/j.ajog.2005.08.047","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5 Suppl.","key":"2259_CR4","doi-asserted-by":"publisher","first-page":"505S","DOI":"10.1016\/8756-3282(95)00258-4","volume":"17","author":"BL Riggs","year":"1995","unstructured":"B.L. Riggs, L.J. Melton III, The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17(5 Suppl.), 505S\u2013511S (1995). https:\/\/doi.org\/10.1016\/8756-3282(95)00258-4","journal-title":"Bone"},{"issue":"2","key":"2259_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7861\/clinmedicine.14-2-187","volume":"14","author":"T Coughlan","year":"2014","unstructured":"T. Coughlan, F. Dockery, Osteoporosis and fracture risk in older people. Clin. Med. 14(2), 187\u2013191 (2014). https:\/\/doi.org\/10.7861\/clinmedicine.14-2-187","journal-title":"Clin. Med."},{"issue":"3","key":"2259_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0749-0690(02)00022-8","volume":"18","author":"M Srivastava","year":"2002","unstructured":"M. Srivastava, C. Deal, Osteoporosis in elderly: prevention and treatment. Clin. Geriatr. Med. 18(3), 529\u2013555 (2002). https:\/\/doi.org\/10.1016\/s0749-0690(02)00022-8","journal-title":"Clin. Geriatr. Med."},{"issue":"1","key":"2259_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0019-5413.73656","volume":"45","author":"DK Dhanwal","year":"2011","unstructured":"D.K. Dhanwal, E.M. Dennison, N.C. Harvey, C. Cooper, Epidemiology of hip fracture: worldwide geographic variation. Indian J. Orthop. 45(1), 15\u201322 (2011). https:\/\/doi.org\/10.4103\/0019-5413.73656","journal-title":"Indian J. Orthop."},{"issue":"8","key":"2259_CR8","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","volume":"37","author":"MT Drake","year":"2015","unstructured":"M.T. Drake, B.L. Clarke, E.M. Lewiecki, The pathophysiology and treatment of osteoporosis. Clin. Ther. 37(8), 1837\u20131850 (2015). https:\/\/doi.org\/10.1016\/j.clinthera.2015.06.006","journal-title":"Clin. Ther."},{"issue":"3","key":"2259_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","volume":"16","author":"JA Kanis","year":"2005","unstructured":"J.A. Kanis, O. Johnell, Requirements for DXA for the management of osteoporosis in Europe. Osteoporos. Int. 16(3), 229\u2013238 (2005). https:\/\/doi.org\/10.1007\/s00198-004-1811-2","journal-title":"Osteoporos. Int."},{"issue":"1","key":"2259_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1359\/jbmr.1997.12.1.24","volume":"12","author":"NF Ray","year":"1997","unstructured":"N.F. Ray, J.K. Chan, M. Thamer, L.J. Melton III, Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J. Bone Miner. Res. 12(1), 24\u201335 (1997). https:\/\/doi.org\/10.1359\/jbmr.1997.12.1.24","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"2259_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.beem.2014.07.002","volume":"28","author":"GR Emkey","year":"2014","unstructured":"G.R. Emkey, S. Epstein, Secondary osteoporosis: pathophysiology & diagnosis. Best practice & research. Clin. Endocrinol. Metab. 28(6), 911\u2013935 (2014). https:\/\/doi.org\/10.1016\/j.beem.2014.07.002","journal-title":"Clin. Endocrinol. Metab."},{"issue":"7","key":"2259_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.7326\/0003-4819-134-7-200104030-00009","volume":"134","author":"DC Bauer","year":"2001","unstructured":"D.C. Bauer, B. Ettinger, M.C. Nevitt, K.L. Stone, Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann. Intern. Med. 134(7), 561\u2013568 (2001). https:\/\/doi.org\/10.7326\/0003-4819-134-7-200104030-00009","journal-title":"Ann. Intern. Med."},{"issue":"20","key":"2259_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1001\/jama.2015.5161","volume":"313","author":"MR Blum","year":"2015","unstructured":"M.R. Blum, D.C. Bauer, T.H. Collet, H.A. Fink, A.R. Cappola, B.R. da Costa, C.D. Wirth, R.P. Peeters, B.O. Asvold, W.P. den Elzen, R.N. Luben, M. Imaizumi, A.P. Bremner, A. Gogakos, R. Eastell, P.M. Kearney, E.S. Strotmeyer, E.R. Wallace, M. Hoff, G. Ceresini, F. Rivadeneira, A.G. Uitterlinden, D.J. Stott, R.G. Westendorp, K.T. Khaw, A. Langhammer, L. Ferrucci, J. Gussekloo, G.R. Williams, J.P. Walsh, P. Juni, D. Aujesky, N. Rodondi, Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313(20), 2055\u20132065 (2015). https:\/\/doi.org\/10.1001\/jama.2015.5161","journal-title":"JAMA"},{"issue":"2","key":"2259_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"MI Surks","year":"2004","unstructured":"M.I. Surks, E. Ortiz, G.H. Daniels, C.T. Sawin, N.F. Col, R.H. Cobin, J.A. Franklyn, J.M. Hershman, K.D. Burman, M.A. Denke, C. Gorman, R.S. Cooper, N.J. Weissman, Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291(2), 228\u2013238 (2004). https:\/\/doi.org\/10.1001\/jama.291.2.228","journal-title":"JAMA"},{"issue":"1","key":"2259_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/jc.2004-1231","volume":"90","author":"H Gharib","year":"2005","unstructured":"H. Gharib, R.M. Tuttle, H.J. Baskin, L.H. Fish, P.A. Singer, M.T. McDermott, Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J. Clin. Endocrinol. Metab. 90(1), 581\u2013585 (2005). https:\/\/doi.org\/10.1210\/jc.2004-1231. discussion 586\u2013587","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2259_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1210\/er.2006-0043","volume":"29","author":"B Biondi","year":"2008","unstructured":"B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29(1), 76\u2013131 (2008). https:\/\/doi.org\/10.1210\/er.2006-0043","journal-title":"Endocr. Rev."},{"issue":"6","key":"2259_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/thy.2010.0417","volume":"21","author":"RS Bahn Chair","year":"2011","unstructured":"R.S. Bahn Chair, H.B. Burch, D.S. Cooper, J.R. Garber, M.C. Greenlee, I. Klein, P. Laurberg, I.R. McDougall, V.M. Montori, S.A. Rivkees, D.S. Ross, J.A. Sosa, M.N. Stan, Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21(6), 593\u2013646 (2011). https:\/\/doi.org\/10.1089\/thy.2010.0417","journal-title":"Thyroid"},{"issue":"4","key":"2259_CR18","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1677\/erc.1.01072","volume":"12","author":"JL Reverter","year":"2005","unstructured":"J.L. Reverter, S. Holgado, N. Alonso, I. Salinas, M.L. Granada, A. Sanmarti, Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Endocr.-Relat. Cancer 12(4), 973\u2013981 (2005). https:\/\/doi.org\/10.1677\/erc.1.01072","journal-title":"Endocr.-Relat. Cancer"},{"issue":"6","key":"2259_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/thy.1999.9.539","volume":"9","author":"A Gurlek","year":"1999","unstructured":"A. Gurlek, O. Gedik, Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid 9(6), 539\u2013543 (1999). https:\/\/doi.org\/10.1089\/thy.1999.9.539","journal-title":"Thyroid"},{"issue":"8","key":"2259_CR20","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1210\/jc.2013-2474","volume":"99","author":"A Leader","year":"2014","unstructured":"A. Leader, R.H. Ayzenfeld, M. Lishner, E. Cohen, D. Segev, D. Hermoni, Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 years. J. Clin. Endocrinol. Metab. 99(8), 2665\u20132673 (2014). https:\/\/doi.org\/10.1210\/jc.2013-2474","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"2259_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"L.A. Stewart, M. Clarke, M. Rovers, R.D. Riley, M. Simmonds, G. Stewart, J.F. Tierney, Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD statement. JAMA 313(16), 1657\u20131665 (2015). https:\/\/doi.org\/10.1001\/jama.2015.3656","journal-title":"JAMA"},{"key":"2259_CR22","unstructured":"G.A.S.B. Wells, D. O\u2019Connell, J. Peterson, V. Welch et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Health Research Institute (2011). www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed Oct 20, 2011"},{"issue":"3","key":"2259_CR23","first-page":"240","volume":"18","author":"T Saler","year":"2014","unstructured":"T. Saler, S. Ahbab, Z.A. Saglam, S.O. Keskek, S. Kurnaz, Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women. Hippokratia 18(3), 240\u2013244 (2014)","journal-title":"Hippokratia"},{"issue":"1","key":"2259_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/cen.13615","volume":"89","author":"R Siru","year":"2018","unstructured":"R. Siru, H. Alfonso, S.A.P. Chubb, J. Golledge, L. Flicker, B.B. Yeap, Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men. Clin. Endocrinol. 89(1), 93\u201399 (2018). https:\/\/doi.org\/10.1111\/cen.13615","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"2259_CR25","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/jbmr.2244","volume":"29","author":"B Abrahamsen","year":"2014","unstructured":"B. Abrahamsen, H.L. Jorgensen, A.S. Laulund, M. Nybo, T.H. Brix, L. Hegedus, Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures-the OPENTHYRO register cohort. J. Bone Miner. Res. 29(9), 2040\u20132050 (2014). https:\/\/doi.org\/10.1002\/jbmr.2244","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"2259_CR26","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1210\/jc.2010-2693","volume":"96","author":"T Vadiveloo","year":"2011","unstructured":"T. Vadiveloo, P.T. Donnan, L. Cochrane, G.P. Leese, The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J. Clin. Endocrinol. Metab. 96(5), 1344\u20131351 (2011). https:\/\/doi.org\/10.1210\/jc.2010-2693","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2259_CR27","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.surg.2011.09.013","volume":"150","author":"I Sugitani","year":"2011","unstructured":"I. Sugitani, Y. Fujimoto, Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery 150(6), 1250\u20131257 (2011). https:\/\/doi.org\/10.1016\/j.surg.2011.09.013","journal-title":"Surgery"},{"issue":"3","key":"2259_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/jbmr.1774","volume":"28","author":"AC Waring","year":"2013","unstructured":"A.C. Waring, S. Harrison, H.A. Fink, M.H. Samuels, P.M. Cawthon, J.M. Zmuda, E.S. Orwoll, D.C. Bauer, A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study. J. Bone Miner. Res. 28(3), 472\u2013479 (2013). https:\/\/doi.org\/10.1002\/jbmr.1774","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"2259_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1359\/jbmr.1997.12.1.72","volume":"12","author":"C Marcocci","year":"1997","unstructured":"C. Marcocci, F. Golia, E. Vignali, A. Pinchera, Skeletal integrity in men chronically treated with suppressive doses of l-thyroxine. J. Bone Miner. Res. 12(1), 72\u201377 (1997). https:\/\/doi.org\/10.1359\/jbmr.1997.12.1.72","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"2259_CR30","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1210\/jc.2014-1051","volume":"99","author":"MC Garin","year":"2014","unstructured":"M.C. Garin, A.M. Arnold, J.S. Lee, J. Robbins, A.R. Cappola, Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study. J. Clin. Endocrinol. Metab. 99(8), 2657\u20132664 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1051","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"21","key":"2259_CR31","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1001\/archinternmed.2010.424","volume":"170","author":"JS Lee","year":"2010","unstructured":"J.S. Lee, P. Buzkova, H.A. Fink, J. Vu, L. Carbone, Z. Chen, J. Cauley, D.C. Bauer, A.R. Cappola, J. Robbins, Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch. Intern. Med. 170(21), 1876\u20131883 (2010). https:\/\/doi.org\/10.1001\/archinternmed.2010.424","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"2259_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1210\/jc.2009-1625","volume":"95","author":"RW Flynn","year":"2010","unstructured":"R.W. Flynn, S.R. Bonellie, R.T. Jung, T.M. MacDonald, A.D. Morris, G.P. Leese, Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J. Clin. Endocrinol. Metab. 95(1), 186\u2013193 (2010). https:\/\/doi.org\/10.1210\/jc.2009-1625","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2259_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.arcmed.2005.09.009","volume":"37","author":"WY Lee","year":"2006","unstructured":"W.Y. Lee, K.W. Oh, E.J. Rhee, C.H. Jung, S.W. Kim, E.J. Yun, H.J. Tae, K.H. Baek, M.I. Kang, M.G. Choi, H.J. Yoo, S.W. Park, Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women. Arch. Med. Res. 37(4), 511\u2013516 (2006). https:\/\/doi.org\/10.1016\/j.arcmed.2005.09.009","journal-title":"Arch. Med. Res."},{"issue":"6","key":"2259_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1530\/eje-13-0546","volume":"169","author":"A Svare","year":"2013","unstructured":"A. Svare, T.I. Nilsen, B.O. Asvold, S. Forsmo, B. Schei, T. Bjoro, A. Langhammer, Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur. J. Endocrinol. 169(6), 845\u2013852 (2013). https:\/\/doi.org\/10.1530\/eje-13-0546","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"2259_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00198-014-2906-z","volume":"26","author":"HM Noh","year":"2015","unstructured":"H.M. Noh, Y.S. Park, J. Lee, W. Lee, A cross-sectional study to examine the correlation between serum TSH levels and the osteoporosis of the lumbar spine in healthy women with normal thyroid function. Osteoporos. Int. 26(3), 997\u20131003 (2015). https:\/\/doi.org\/10.1007\/s00198-014-2906-z","journal-title":"Osteoporos. Int."},{"issue":"3","key":"2259_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1089\/thy.2014.0287","volume":"25","author":"LY Wang","year":"2015","unstructured":"L.Y. Wang, A.W. Smith, F.L. Palmer, R.M. Tuttle, A. Mahrous, I.J. Nixon, S.G. Patel, I. Ganly, J.A. Fagin, L. Boucai, Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma. Thyroid 25(3), 300\u2013307 (2015). https:\/\/doi.org\/10.1089\/thy.2014.0287","journal-title":"Thyroid"},{"issue":"1","key":"2259_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/joim.12688","volume":"283","author":"D Segna","year":"2018","unstructured":"D. Segna, D.C. Bauer, M. Feller, C. Schneider, H.A. Fink, C.E. Aubert, T.H. Collet, B.R. da Costa, K. Fischer, R.P. Peeters, A.R. Cappola, M.R. Blum, H.A. van Dorland, J. Robbins, K. Naylor, R. Eastell, A.G. Uitterlinden, F. Rivadeneira Ramirez, A. Gogakos, J. Gussekloo, G.R. Williams, A. Schwartz, J.A. Cauley, D.A. Aujesky, H.A. Bischoff-Ferrari, N. Rodondi, Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts. J. Intern. Med. 283(1), 56\u201372 (2018). https:\/\/doi.org\/10.1111\/joim.12688","journal-title":"J. Intern. Med."},{"issue":"3","key":"2259_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7326\/m14-0125","volume":"161","author":"CD Wirth","year":"2014","unstructured":"C.D. Wirth, M.R. Blum, B.R. da Costa, C. Baumgartner, T.H. Collet, M. Medici, R.P. Peeters, D. Aujesky, D.C. Bauer, N. Rodondi, Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann. Intern. Med. 161(3), 189\u2013199 (2014). https:\/\/doi.org\/10.7326\/m14-0125","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"2259_CR39","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/105072503322238854","volume":"13","author":"P Vestergaard","year":"2003","unstructured":"P. Vestergaard, L. Mosekilde, Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis. Thyroid 13(6), 585\u2013593 (2003). https:\/\/doi.org\/10.1089\/105072503322238854","journal-title":"Thyroid"},{"issue":"9821","key":"2259_CR40","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/s0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379(9821), 1142\u20131154 (2012). https:\/\/doi.org\/10.1016\/s0140-6736(11)60276-6","journal-title":"Lancet"},{"issue":"6","key":"2259_CR41","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0002-9343(87)90219-1","volume":"82","author":"DS Ross","year":"1987","unstructured":"D.S. Ross, R.M. Neer, E.C. Ridgway, G.H. Daniels, Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with l-thyroxine. Am. J. Med. 82(6), 1167\u20131170 (1987). https:\/\/doi.org\/10.1016\/0002-9343(87)90219-1","journal-title":"Am. J. Med."},{"issue":"10","key":"2259_CR42","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1172\/jci63948","volume":"122","author":"R Baliram","year":"2012","unstructured":"R. Baliram, L. Sun, J. Cao, J. Li, R. Latif, A.K. Huber, T. Yuen, H.C. Blair, M. Zaidi, T.F. Davies, Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J. Clin. Investig. 122(10), 3737\u20133741 (2012). https:\/\/doi.org\/10.1172\/jci63948","journal-title":"J. Clin. Investig."},{"issue":"5","key":"2259_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2265.1993.tb02403.x","volume":"39","author":"J Foldes","year":"1993","unstructured":"J. Foldes, G. Tarjan, M. Szathmari, F. Varga, I. Krasznai, C. Horvath, Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin. Endocrinol. 39(5), 521\u2013527 (1993). https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb02403.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"2259_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2265.1994.tb02571.x","volume":"41","author":"AH Mudde","year":"1994","unstructured":"A.H. Mudde, A.J. Houben, A.C. Nieuwenhuijzen Kruseman, Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin. Endocrinol. 41(4), 421\u2013424 (1994). https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02571.x","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"2259_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2265.1998.00427.x","volume":"48","author":"J Faber","year":"1998","unstructured":"J. Faber, I.W. Jensen, L. Petersen, B. Nygaard, L. Hegedus, K. Siersbaek-Nielsen, Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin. Endocrinol. 48(3), 285\u2013290 (1998). https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00427.x","journal-title":"Clin. Endocrinol."},{"issue":"41","key":"2259_CR46","doi-asserted-by":"publisher","first-page":"16568","DOI":"10.1073\/pnas.1308755110","volume":"110","author":"Y Miyauchi","year":"2013","unstructured":"Y. Miyauchi, Y. Sato, T. Kobayashi, S. Yoshida, T. Mori, H. Kanagawa, E. Katsuyama, A. Fujie, W. Hao, K. Miyamoto, T. Tando, H. Morioka, M. Matsumoto, P. Chambon, R.S. Johnson, S. Kato, Y. Toyama, T. Miyamoto, HIF1alpha is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc. Natl Acad. Sci. USA 110(41), 16568\u201316573 (2013). https:\/\/doi.org\/10.1073\/pnas.1308755110","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"3","key":"2259_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2302\/kjm.2015-0003-RE","volume":"64","author":"T Miyamoto","year":"2015","unstructured":"T. Miyamoto, Mechanism underlying post-menopausal osteoporosis: HIF1alpha is required for osteoclast activation by estrogen deficiency. Keio J. Med. 64(3), 44\u201347 (2015). https:\/\/doi.org\/10.2302\/kjm.2015-0003-RE","journal-title":"Keio J. Med."},{"issue":"3","key":"2259_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1530\/eje.0.1360277","volume":"136","author":"J Foldes","year":"1997","unstructured":"J. Foldes, P. Lakatos, J. Zsadanyi, C. Horvath, Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism. Eur. J. Endocrinol. 136(3), 277\u2013281 (1997). https:\/\/doi.org\/10.1530\/eje.0.1360277","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"2259_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/s1297-319x(01)00327-x","volume":"68","author":"C Cormier","year":"2001","unstructured":"C. Cormier, J.C. Souberbielle, A. Kahan, DHEA in bone and joint diseases. Jt. Bone Spine Rev. Rhum. 68(6), 588\u2013594 (2001). https:\/\/doi.org\/10.1016\/s1297-319x(01)00327-x","journal-title":"Jt. Bone Spine Rev. Rhum."},{"issue":"1","key":"2259_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/endo:11:1:1","volume":"11","author":"CM Gordon","year":"1999","unstructured":"C.M. Gordon, J. Glowacki, M.S. LeBoff, DHEA and the skeleton (through the ages). Endocrine 11(1), 1\u201311 (1999). https:\/\/doi.org\/10.1385\/endo:11:1:1","journal-title":"Endocrine"},{"key":"2259_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/bs.vh.2018.01.005","volume":"108","author":"S Zhou","year":"2018","unstructured":"S. Zhou, J. Glowacki, Dehydroepiandrosterone and bone. Vitam. Hormones 108, 251\u2013271 (2018). https:\/\/doi.org\/10.1016\/bs.vh.2018.01.005","journal-title":"Vitam. Hormones"},{"issue":"6","key":"2259_CR52","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1158\/0008-5472.can-04-3079","volume":"65","author":"S Liu","year":"2005","unstructured":"S. Liu, H. Ishikawa, F.J. Li, Z. Ma, K. Otsuyama, H. Asaoku, S. Abroun, X. Zheng, N. Tsuyama, M. Obata, M.M. Kawano, Dehydroepiandrosterone can inhibit the proliferation of myeloma cells and the interleukin-6 production of bone marrow mononuclear cells from patients with myeloma. Cancer Res. 65(6), 2269\u20132276 (2005). https:\/\/doi.org\/10.1158\/0008-5472.can-04-3079","journal-title":"Cancer Res."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-020-02259-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:08:02Z","timestamp":1616458082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-020-02259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02259-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}